Technical Articles
Protein degrader
Application of CRBN Ligand Screening Based on TR-FRET Technology in the Development of Protein Degraders
Thalidomide is a compound composed of glutarimide and phthalimide, and its derivatives lenalidomide and pomalidomide are collectively known as immunomodulatory imide drugs, primarily used to treat hematologic malignancies such as multiple myeloma.
View details
- Drug Research
- TR-FRET Technology
- CRBN Ligand
- Protein Degrader
Research Progress on GSPT1 Protein Degraders and the Application Value of DDB1-CRBN&GSPT1 PROTAC Reagent Kits
Targeted protein degradation (TPD) is a promising new direction in anticancer therapy, with molecular glues and PROTAC strategies demonstrating significant potential in inducing the degradation of disease-causing proteins.
View details
- Cancer
- DDB1-CRBN&GSPT1 PROTAC Kit
- Malignant tumor
- Protein degrader
- 1













